Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction

Abstract Aims Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients with HF with mid‐range EF (HFmrEF). M...

Full description

Bibliographic Details
Main Authors: Nobuyuki Enzan, Shouji Matsushima, Tomomi Ide, Hidetaka Kaku, Taiki Higo, Miyuki Tsuchihashi‐Makaya, Hiroyuki Tsutsui
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:ESC Heart Failure
Subjects:
Spironolactone
Heart failure with mid‐range ejection fraction
Outcomes
Rehospitalization
Online Access:https://doi.org/10.1002/ehf2.12571

Similar Items

Similar Items